Motor Neuron Disease Clinical Trials
There are 32 actively recruiting motor neuron disease clinical trials across 20 countries. Studies span Not Applicable, Phase 2, Phase 3. Top locations include Sheffield, United Kingdom, Edinburgh, United Kingdom, Bethesda, Maryland, United States. Updated daily from ClinicalTrials.gov.
Motor Neuron Disease Trials at a Glance
32 actively recruiting trials for motor neuron disease are listed on ClinicalTrialsFinder across 6 cities in 20 countries. The largest study group is Not Applicable with 13 trials, with the heaviest enrollment activity in Sheffield, Edinburgh, and Bethesda. Lead sponsors running motor neuron disease studies include Synchron, Inc., National Institute of Neurological Disorders and Stroke (NINDS), and Istituto Auxologico Italiano.
Top cities for motor neuron disease trials
Treatments under study
About Motor Neuron Disease Clinical Trials
Looking for clinical trials for Motor Neuron Disease? There are currently 30 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.
Below you can browse trials, sign up for alerts when new Motor Neuron Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.
Frequently Asked Questions
Common questions about Motor Neuron Disease clinical trials
A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.
All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.
Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.
Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.
Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.
Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.
Showing 1–20 of 32 trials